Showing 111-120 of 2120 results for "".
Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.- Building a better UPDRShttps://practicalneurology.com/columns/practice-management/building-a-better-updrs/31010/Since the late 1980s, the Unified Parkinson’s Disease Rating Scale (UPDRS) has been a cornerstone in assessing Parkinson’s Disease (PD), primarily focusing on motor symptoms such as finger tapping, fist opening, and rising from a chair. However, over the past two decades, advancements in PD research
Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Unraveling the Impact of Environmental Factors on Sleep Quality and Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/unraveling-the-impact-of-environmental-factors-on-sleep-quality-and-parkinson-disease/32197/A review of the effects of various environmental factors—extreme temperatures, air and noise pollution, chemical exposures, and heavy metals—on both sleep and Parkinson disease.Clinical Trials for Huntington Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/clinical-trials-for-huntington-disease/31681/The promise for potential disease-modifying research is strong, although continued discovery uncovers new questions and challenges to overcome.Epilepsy Essentials: VideoEEG Monitoring
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-videoeeg-monitoring/31892/In this 2-part special report, complexities of performing and interpreting videoEEG are demystified.Disclosing Risk Factors to Individuals Without Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disclosing-risk-factors-to-individuals-withoutcognitive-impairment/31535/Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.Multiple Sclerosis Minute: Novel Treatment Options for Neuromyelitis Optica Spectrum Disorder
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-novel-treatment-options-for-neuromyelitis-opticaspectrum-disorder/31844/Relapse prevention is critical for preventing the accumulation of disability in NMOSD and new monoclonal antibody therapies are highly effective at doing so.Movement Disorders Moment: Neuropsychiatric Symptoms in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-neuropsychiatric-symptoms-in-parkinson-disease/31880/Broader awareness and assessment of neuropsychiatric symptoms are needed.Advances in Neuromodulation for Essential Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/advances-in-neuromodulation-for-essential-tremor/32163/Advancements in neuromodulation continue to expand treatment options for medication-refractory essential tremor.